articleThe Lancet OncologyApr 7, 2006Closed access

CHOP-like chemotherapy plus rituximab versus CHOP-like chemotherapy alone in young patients with good-prognosis diffuse large-B-cell lymphoma: a randomised controlled trial by the MabThera International Trial (MInT) Group

Saarland University · University of Göttingen · +20 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

2,081
total citations
FWCI
73.95
Percentile
100%
References
19
Citations per year

Authors

24

Topics & keywords

Keywords
  • Medicine
  • Rituximab
  • CHOP
  • Internal medicine
  • Vincristine
  • International Prognostic Index
  • Chemotherapy
  • Clinical endpoint
UN Sustainable Development Goals
  • Partnerships for the goals
No related works found for this paper.